Advertisement

Pathology of Cardiac Allograft Vasculopathy (Chronic Rejection)

  • A. G. Rose

Abstract

In the quarter-century since the first human heart transplant was performed by Barnard in 1967[1], this operation has become a well-established therapy for treating irremediable cardiac failure. Survival rates have progressively improved[2],[3] (Chapters 43 and 44) and the 1-year survival following the operation is 80% or greater. Over 20 000 heart transplants have been performed worldwide. In patients who die in the first few months after cardiac transplantation when immunosuppression is maximal, infection is a major cause of death[4],[5] (Chapter 32). Rejection is also an important factor which, if not primarily responsible for the patient’s death, contributes significantly to it, even when overwhelming infection is present[6],[7]. The clinical pattern of acute cardiac rejection, and the role of endomyocardial biopsy in its diagnosis, have been outlined in Chapter 30.

Keywords

Acute Rejection Cardiac Transplantation Chronic Rejection Endomyocardial Biopsy Cardiac Allograft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bernard CN. The operation: A human cardiak transplant; interim report of a successful operation performed at Groote Schuar Hospital, Cape Town. S. Afr Med J. 1967;41:1271Google Scholar
  2. 2.
    Jamieson SW, Oyer PE, Reitz BA, et al. Cardiac transplantation at Stanford. Heart Transplant. 1981;1:86Google Scholar
  3. 3.
    Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The registry of the international society for heart and lung transplantation. eleventh official report, 1994. J Heart Lung Transplant, 1994;13:561.PubMedGoogle Scholar
  4. 4.
    Baumgarner WA, Reitz BA, Oyer PE, Stinson EE, Shumway NE. Cardiac homotransplantation. Curr Probl Surg. 1979;16:3Google Scholar
  5. 5.
    Cooper DKC, Lanza RP, Oliver S et al. Infectious complications after heart transplantation. Thorax. 1983;38:822.PubMedCrossRefGoogle Scholar
  6. 6.
    Uys CJ, Rose AG, Barnard CN. The pathology of human heart transplantation. An assessment after 11 years’ experience at Groote Schuur Hospital. S Afr Med J. 1979;56:887.PubMedGoogle Scholar
  7. 7.
    Uys CJ, Rose AG. Cardiac transplantation. Aspects of the pathology. In: Sommers SC, Rosen PP. editors. Pathology Annual, vol. 17. New York: Appleton-Century Crofts; 1983:147–78.Google Scholar
  8. 8.
    Lower RR, Kontos HA, Kosek JC, Sewell DH, Graham WH. Experiences in heart transplantation. Am J Cardiol. 1968;22:766.PubMedCrossRefGoogle Scholar
  9. 9.
    Thomson JG. Production of severe atheroma in a transplanted heart. Lancet. 1969;2:1088.PubMedCrossRefGoogle Scholar
  10. 10.
    Bieber CP, Stinson EB, Shumway NE, Payne R, Kosek J. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation. 1970;4l:753.Google Scholar
  11. 11.
    Milam JD., Shipkey FH, Lind CJ et al. Morphologic findings in human allografts. Circulation. 1970;41:519.PubMedGoogle Scholar
  12. 12.
    Kosek JC, Bieber CP, Lower RR. Heart graft arteriosclerosis. Transplant Proc., 1974;3:512.Google Scholar
  13. 13.
    Sinclair RA, Andres GA, Hsu KC. Immunofluorescent studies of the arterial lesion in rat cardiac allografts. Arch Pathol. 1972;94:331.PubMedGoogle Scholar
  14. 14.
    Laden AM. Experimental atherosclerosis in rat and rabbit cardiac allografts. Arch Pathol. 1972;93:240.PubMedGoogle Scholar
  15. 15.
    Laden AM, Sinclair RA, Ruskiewica M. Vascular changes in experimental allografts. Transplant Proc. 1973;5:737.PubMedGoogle Scholar
  16. 16.
    Alonso DR, Storek PK, Minick CR. Studies in the pathogenesis of atherosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol. 1977;87:415.PubMedGoogle Scholar
  17. 17.
    Rose AG, Uys CJ, Cooper DKC, Barnard CN. Donor heart morphology twelve and a half years after orthotopic transplantation. Heart Transplant. 1982; 1:329.Google Scholar
  18. 18.
    Uys CJ, Rose AG. Pathologic findings in long-term cardiac transplants. Arch Pathol Lab Med. 1984;108:112.PubMedGoogle Scholar
  19. 19.
    Rose AG, Viviers L, Odell JA. Pathology of chronic cardiac rejection: an analysis of the epicardial and intramyocardial coronary arteries and myocardial alterations in 43 human allografts. J Cardiovasc. Pathol. 1993;2:7.CrossRefGoogle Scholar
  20. 20.
    Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant. 1992;11:S38.PubMedGoogle Scholar
  21. 21.
    Rose AG, Jones J, Brink J, Emery R, Shumway SJ, Bolmann RM III. Causes of death within 30 days following cardiac transplantation: a study of 47 autopsy patients. (Manuscript in preparation).Google Scholar
  22. 22.
    Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc. 1987;19:19.PubMedGoogle Scholar
  23. 23.
    Young JB. Cardiac allograft arteriopathy: an ischemic burden of a different sort. Am J Cardiol. 1992;70:9F.PubMedCrossRefGoogle Scholar
  24. 24.
    Schroeder JS, Gao S-J, Alderman EL, Hunt SA, Stinson E. Dilitiazem inhibits development of early accelerated transplant coronary disease-an interim report. Circulation. 1990;82:III–257 (abstract).Google Scholar
  25. 25.
    Kobashigawa JA, Katznelson S, Laks H et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621.PubMedCrossRefGoogle Scholar
  26. 26.
    Valantine HA, Schroeder JS. Recent advances in cardiac transplantation. N Engl J Med. 1995;333:660.PubMedCrossRefGoogle Scholar
  27. 27.
    Johnson DA, Alderman EL, Schroeder JS et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol. 1991;17:449.PubMedCrossRefGoogle Scholar
  28. 28.
    Wymore P, Yedlicka JW, Garcia-Medina V et al. The incidence of myocardial bridges in heart transplants. Cardiovasc Interventional Radiol. 1989;12:202.CrossRefGoogle Scholar
  29. 29.
    von Scheidt W, Erdman E. Dilated angiopathy: a specific subtype of allograft coronary artery disease. J Heart Lung Transplant. 1991;10:698.Google Scholar
  30. 30.
    Gravanis MB. Allograft heart accelerated atherosclerosis: evidence for cell-mediated immunity in pathogenesis. Mod Pathol. 1989;2:495.PubMedGoogle Scholar
  31. 31.
    Miller LW. Allograft vascular disease: a disease not limited to hearts. J Heart Lung Transplant. 1992;11:S32.PubMedGoogle Scholar
  32. 32.
    Libby P, Swanson SJ, Tanaka H, Murray A, Schoon FJ, Pober JS. Immunopathology of coronary arteriosclerosis in transplanted hearts. J Heart Lung Transplant. 1992;11:S5.PubMedGoogle Scholar
  33. 33.
    Watschinger B, Sayegh MH, Hancock WW, Russell ME. Up-regulalion of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol. 1995;146:1065.PubMedGoogle Scholar
  34. 34.
    Hruban RH, Hutchins GM. T-lymphocytes and accelerated arteriosclerosis. Cor Notes (Society for Cardiovascular Pathology). 1992;7:2.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • A. G. Rose

There are no affiliations available

Personalised recommendations